Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 130
- −2 vs. Q2 2022
- Portfolio value
- $1.92B
- +$117.7M (+6.5%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 89,778,234 | $215.5M | 11.2% | +18,599,870+26.1% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,325,000 | $92.5M | 4.8% | +225,000+20.5% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 650,000 | $87.6M | 4.6% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,000,000 | $68.3M | 3.6% | +1,000,000 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 6,000,000 | $63.4M | 3.3% | −1,000,000−14.3% | Reduced | – |
| MORFMorphic Holding, Inc. | COM | 2,150,000 | $60.8M | 3.2% | +500,000+30.3% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 8,750,034 | $60.6M | 3.2% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,053,403 | $58.6M | 3.1% | +1,153,403+128.2% | Added | History |
| FATEFate Therapeutics Inc | COM | 2,600,000 | $58.3M | 3.0% | 00.0% | Unchanged | History |
| WWWW International, Inc. | COM | 14,818,300 | $58.2M | 3.0% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 2,000,000 | $56.5M | 2.9% | +500,000+33.3% | Added | History |
| IGMSIGM Biosciences, Inc. | COM | 2,450,000 | $55.7M | 2.9% | +450,000+22.5% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 150,000 | $53.0M | 2.8% | −250,000−62.5% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $48.5M | 2.5% | −275,000−21.6% | Reduced | History |
| SGENSeagen Inc. | COM | 350,000 | $47.9M | 2.5% | −175,000−33.3% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 5,577,167 | $44.0M | 2.3% | +3,253,796+140.0% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 4,000,000 | $41.8M | 2.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,246,624 | $38.9M | 2.0% | +887,656+37.6% | Added | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $36.8M | 1.9% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $34.9M | 1.8% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,500,000 | $32.7M | 1.7% | +500,000+50.0% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,454,716 | $32.5M | 1.7% | +754,716+107.8% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 750,000 | $29.4M | 1.5% | +300,000+66.7% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 125,000 | $28.1M | 1.5% | +125,000 | New | History |
| ERASErasca, Inc. | COM | 3,172,221 | $24.7M | 1.3% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 2,285,574 | $20.8M | 1.1% | +1,164,383+103.9% | Added | History |
| EQRXEQRx, Inc. | COM | 4,000,000 | $19.8M | 1.0% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $18.4M | 1.0% | 00.0% | Unchanged | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $17.5M | 0.9% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $15.5M | 0.8% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $15.4M | 0.8% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,100,000 | $15.0M | 0.8% | +50,000+4.8% | Added | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $14.9M | 0.8% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,200,000 | $14.9M | 0.8% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $14.8M | 0.8% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $13.7M | 0.7% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 750,000 | $13.5M | 0.7% | +750,000 | New | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $12.3M | 0.6% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 3,000,000 | $10.8M | 0.6% | 00.0% | Unchanged | History |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $10.1M | 0.5% | 00.0% | Unchanged | History |
| SESea Ltd | SPONSORD ADS | 172,500 | $9.67M | 0.5% | +115,000+200.0% | Added | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,463,829 | $9.43M | 0.5% | +1,063,829+266.0% | AddedConverted for a 1-for-10 split | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,193,030 | $8.59M | 0.4% | +600,000+101.2% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $8.49M | 0.4% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 4,000,000 | $8.20M | 0.4% | +1,000,000+33.3% | Added | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,883,200 | $8.01M | 0.4% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $7.62M | 0.4% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $7.52M | 0.4% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.45M | 0.4% | 00.0% | Unchanged | – |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $6.67M | 0.3% | 00.0% | Unchanged | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $5.77M | 0.3% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $5.50M | 0.3% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $5.43M | 0.3% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $5.17M | 0.3% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $5.13M | 0.3% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $5.10M | 0.3% | 00.0% | Unchanged | – |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 450,000 | $4.79M | 0.2% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $4.79M | 0.2% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $4.60M | 0.2% | 00.0% | Unchanged | History |
| Exscientia PLC30223G102 | ADS | 550,000 | $4.52M | 0.2% | 00.0% | Unchanged | – |
| NTRANatera, Inc. | COM | 100,000 | $4.38M | 0.2% | +100,000 | New | History |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $4.08M | 0.2% | 00.0% | Unchanged | – |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $3.94M | 0.2% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 573,062 | $3.84M | 0.2% | +573,062 | New | History |
| THRDThird Harmonic Bio, Inc. | COM | 200,000 | $3.79M | 0.2% | +200,000 | New | History |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $3.73M | 0.2% | 00.0% | Unchanged | History |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $3.71M | 0.2% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $3.66M | 0.2% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $3.54M | 0.2% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $3.52M | 0.2% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $3.41M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $3.21M | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 250,000 | $3.21M | 0.2% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $3.16M | 0.2% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $2.78M | 0.1% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $2.77M | 0.1% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2.72M | 0.1% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $2.48M | 0.1% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $2.48M | 0.1% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $2.40M | 0.1% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $2.39M | 0.1% | 00.0% | Unchanged | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $2.32M | 0.1% | 00.0% | Unchanged | History |
| NERVMinerva Neurosciences, Inc. | COM NEW | 250,000 | $2.31M | 0.1% | +250,000 | New | History |
| SNTISenti Biosciences Holdings, Inc. | COM | 1,055,555 | $2.29M | 0.1% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $2.26M | 0.1% | 00.0% | Unchanged | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $2.25M | 0.1% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $2.22M | 0.1% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 700,000 | $2.21M | 0.1% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 550,000 | $2.19M | 0.1% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $2.18M | 0.1% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $2.01M | 0.1% | 00.0% | Unchanged | History |
| GRTSGritstone bio, Inc. | COM | 750,000 | $1.93M | 0.1% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 661,009 | $1.89M | 0.1% | 00.0% | Unchanged | History |
| YI111, Inc. | ADS | 686,431 | $1.84M | 0.1% | −279,918−29.0% | Reduced | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 1,000,000 | $1.56M | 0.1% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 125,000 | $1.49M | 0.1% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $1.40M | 0.1% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $1.35M | 0.1% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $1.31M | 0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 1,500,000 | $1.29M | 0.1% | 00.0% | Unchanged | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2022 (12)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 600,000 | $87.5M | 4.9% | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $7.79M | 0.4% | History |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $5.60M | 0.3% | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $3.60M | 0.2% | History |
| IVVDInvivyd, Inc. | COM | 1,000,000 | $3.28M | 0.2% | History |
| CINCCinCor Pharma, Inc. | COM | 137,010 | $2.58M | 0.1% | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 75,000 | $1.45M | 0.1% | History |
| HIPOHippo Holdings Inc. | COMMON STOCK | 600,000 | $527.0K | <0.1% | History |
| CLFCleveland-Cliffs Inc. | COM | 25,000 | $384.0K | <0.1% | History |
| UNGUnited States Natural Gas Fund, LP | UNIT PAR | 20,000 | $380.0K | <0.1% | History |
| BBWIBath & Body Works, Inc. | COM | 12,500 | $337.0K | <0.1% | History |
| KLDOKaleido Biosciences, Inc. | COM | 500,500 | $31.0K | <0.1% | History |